WINNERS & LOSERS: GlobalData sinks; Sage rises on AI safety fear
(Alliance News) - The following are the leading risers and fallers among FTSE 100 and 250 index constituents on Monday. Read More
| Price | 1,840.00p on 14-09-2026 at 09:58:24 |
|---|---|
| Change | 69.50p 3.93% |
| Buy | 1,840.50p |
| Sell | 1,840.00p |
| Last Trade: | Sell 359.00 at 1,840.00p |
| Day's Volume: | 803,167 |
| Last Close: | 1,770.50p |
| Open: | 1,800.00p |
| ISIN: | GB00BN7SWP63 |
| Day's Range | 1,789.50p - 1,841.50p |
| 52wk Range: | 1,455.00p - 2,282.00p |
| Market Capitalisation: | £73.73b |
| VWAP: | 1,820.86933p |
| Shares in Issue: | 4.01b |
Glaxosmithkline (GSK) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Sell* | 359 | 1,840.00p | Automatic Execution |
10:58:09 - 14-Sep-26 |
| Sell* | 112 | 1,840.00p | Automatic Execution |
10:58:09 - 14-Sep-26 |
| Sell* | 221 | 1,840.00p | Automatic Execution |
10:58:09 - 14-Sep-26 |
| Sell* | 109 | 1,840.50p | Automatic Execution |
10:58:08 - 14-Sep-26 |
| Sell* | 133 | 1,840.50p | Automatic Execution |
10:58:08 - 14-Sep-26 |
| Sell* | 376 | 1,840.50p | Automatic Execution |
10:58:08 - 14-Sep-26 |
| Sell* | 250 | 1,840.50p | Automatic Execution |
10:58:08 - 14-Sep-26 |
| Sell* | 783 | 1,841.00p | Automatic Execution |
10:58:08 - 14-Sep-26 |
| Sell* | 299 | 1,840.95p | Ordinary |
10:57:54 - 14-Sep-26 |
| Sell* | 150 | 1,841.00p | Automatic Execution |
10:57:41 - 14-Sep-26 |
Glaxosmithkline (GSK) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 11th Sep 2026 3:30 pm | RNS | Director/PDMR Shareholding |
| 10th Sep 2026 3:30 pm | RNS | Director/PDMR Shareholding |
| 10th Sep 2026 7:00 am | RNS | Japan approval of Shingrix in a prefilled syringe |
| 9th Sep 2026 3:30 pm | RNS | Director/PDMR Shareholding |
| 9th Sep 2026 3:30 pm | RNS | Director/PDMR Shareholding |
| 1st Sep 2026 3:00 pm | RNS | Total Voting Rights |
| 1st Sep 2026 7:00 am | RNS | mRNA flu vaccine candidate to advance to phase III |
| 26th Aug 2026 3:30 pm | RNS | Director/PDMR Shareholding |
| 24th Aug 2026 3:30 pm | RNS | Director/PDMR Shareholding |
| 24th Aug 2026 7:02 am | RNS | First global approval for Hibsago in Japan |